The JSE was weaker on Tuesday, while its global counterparts were mixed as investors digest the news of the development of a coronavirus vaccine.

On Monday, drugmakers Pfizer and BioNTech announced that the preliminary results of their vaccine show it prevents more than 90% of infections, giving hope that there may be a return to economic normality in the coming months...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now